CYTK
Cytokinetics, Incorporated
Stock
$65.62−0.29 (−0.44%)Close Oct 1, 2026
| Shares outstanding (Q2 2026) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| 139.0M | +16.2% | 11.6% | 12.0% |
| Shares outstanding (Q2 2026) | 139.0M |
|---|---|
| YoY | +16.2% |
| 5-year CAGR | 11.6% |
| 10-year CAGR | 12.0% |
Shares outstanding
| Period | Shares outstanding | YoY |
|---|---|---|
| 2025 | 123.2M | +4.0% |
| 2024 | 118.4M | +15.0% |
| 2023 | 103.0M | +8.2% |
| 2022 | 95.2M | +12.1% |
| 2021 | 84.9M | +19.3% |
| 2020 | 71.1M | +19.6% |
| 2019 | 59.5M | +8.3% |
| 2018 | 54.9M | +1.6% |
| 2017 | 54.0M | +29.4% |
| 2016 | 41.7M | +5.4% |
| 2015 | 39.6M | +2.4% |
| 2014 | 38.7M | +7.2% |
| 2013 | 36.1M | +49.8% |
| 2012 | 24.1M | +89.1% |
| 2011 | 12.7M | — |